Greenvale Capital LLP

CIK 0001768041 · LONDON, X0 · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Greenvale Capital LLP reported 11 positions worth $915.6M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: ZETA (19.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$915.6M
2026 Q2
Positions
11
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
99.3%
Est. Net Flow (Q)
2026 Q2
10 / 11 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1ZETAZETA GLOBAL HOLDINGS CORPSH$182.1M19.89%9,255,000
2RUNSUNRUN INCSH$178.0M19.44%13,304,181
3OKTAOKTA INCSH$109.2M11.92%800,000
4SNSHARKNINJA INCSH$101.3M11.06%665,000
5FCNFTI CONSULTING INCSH$98.3M10.74%660,000
6ACELACCEL ENTERTAINMENT INCSH$71.0M7.76%5,632,300
7KSPIKASPI KZ JSCSH$57.7M6.30%665,590
8SHLSSHOALS TECHNOLOGIES GROUP INSH$42.1M4.60%4,250,000
9TXRHTEXAS ROADHOUSE INCSH$38.6M4.22%200,000
10WAYWAYSTAR HLDG CORPSH$30.8M3.36%1,500,000

The free plan shows the top 10 positions. The remaining 1 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Greenvale Capital LLP hold as of Q2 2026?

Greenvale Capital LLP reported 11 positions worth $915.6M in its Q2 2026 13F filing. Largest positions: ZETA (19.9%), RUN (19.4%), OKTA (11.9%), SN (11.1%) and FCN (10.7%).

What did Greenvale Capital LLP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Greenvale Capital LLP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.